RNAConnectĀ® Launches UltraMarathonRTĀ® Kit to Transform Short-Read RNA Sequencing
RNAConnect today announced the commercial launch of the UltraMarathonRTĀ® (uMRT) cDNA Synthesis and Amplification Kit, a next-generation tool designed...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
RNAConnect today announced the commercial launch of the UltraMarathonRTĀ® (uMRT) cDNA Synthesis and Amplification Kit, a next-generation tool designed...
SHIRLEY, N.Y., August 27, 2025 ā American Regent, Inc.Ā® has announced the commercial launch of Gvoke VialDx⢠(glucagon injection),...
